RIVNJuly 28, 2026 at 3:09 PM UTCAutomobiles & Components

Rivian's Q2 Delivery Beat Sets Stage for Margin Test on July 30

Read source article

What happened

Rivian pre-announced a beat of second-quarter production and delivery guidance, raising its full-year delivery target to 65,000-70,000 units. The market, however, remains focused on July 30 earnings, where analysts expect heavier losses despite the volume surprise. The DeepValue master report maintained a WAIT rating, emphasizing that consolidated gross profit still relies on Software and Services while automotive gross profit was negative $62 million in Q1. The upcoming report must show automotive margin improvement and clarity on R2 mix to validate the profitability path. Without evidence that factory absorption is improving, the stock's current price around $16.66 already prices in optimistic execution that has yet to materialize.

Implication

The July 30 report is a critical checkpoint: if automotive gross profit remains deeply negative, the WAIT rating holds, and the stock could retreat toward the $14 attractive entry level. Conversely, a clear improvement, combined with evidence that R2 volumes are driving better factory utilization, would strengthen the base case and open a path to the $17-21 range. Investors should also monitor updates on Uber's initial $300 million close and the October Volkswagen JV loan window, as these milestone-based capital inflows are essential to bridge the company without further dilution. The consumer response to R2's premium trim launch will indicate whether the broader affordability story can unfold on schedule. For now, the risk-reward remains balanced, and patience is warranted.

Thesis delta

The delivery beat does not alter the core investment thesis: Rivian must still prove that automotive gross profit can turn positive through higher R2 volumes and factory absorption. While the raised guidance is a positive signal, it does not yet confirm that the company is on a path to self-sustaining profitability. The WAIT rating remains appropriate until Q2 results provide concrete evidence of manufacturing margin improvement.

Confidence

Moderate